ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710904 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710904; 2) Community: the network communities that were significantly associated with the response to NSC 710904; 3) Molecule: the relationships between components within communities and NSC 710904; 4) MDR: the compounds that were significantly associated with the NSC 710904.

NSC Compound Enrichment Correlation
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0202245331784478 0.52812716
NSC 641319 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride 0.0202245331784478 0.35843836
NSC 642306 Null 0.0202245331784478 0.0054204688
NSC 645777 STREPTOMYCES ANTIBIOTIC DC-107 0.0202245331784478 0.48714499
NSC 647328 Null 0.0202245331784478 0.48615429
NSC 650351 Null 0.0202245331784478 0.43111726
NSC 654509 Pirarubicin HCl 0.0202245331784478 0.32874872
NSC 658828 Null 0.0202245331784478 0.48720331
NSC 666112 Null 0.0202245331784478 0.52693745
NSC 670226 trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid 0.0202245331784478 0.27539958
Total:107  Current:53    [First] [Prev] [Next] [Last]